eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Genzyme Therapeutics
4320 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1483 505 515
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Fax: +44(0)1483 554 805

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 16/03/2011
PIL Renagel 800 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 30/06/2010 and displayed until 16/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 04/01/2010 and displayed until 30/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
Updated on 27/08/2009 and displayed until 04/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 18/09/2008 and displayed until 27/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 04/08/2008 and displayed until 18/09/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 18/06/2007 and displayed until 04/08/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to date of revision
  • Change to drug interactions
Updated on 14/08/2006 and displayed until 18/06/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  sevelamer hydrochloride